Political Radar


July 27th, 2013

The Washington Post reported on Saturday that an aide to U.S. Rep. Colleen Hanabusa told colleagues in June that the Pharmaceutical Research and Manufacturers of America, a trade group for the drug industry, wanted to run a campaign to help Hanabusa's Democratic primary challenge to U.S. Sen. Brian Schatz.

Interest groups are not allowed under federal campaign-finance law to coordinate independent expenditures with political candidates.

PhRMA told the Post that it was considering a fundraiser for Hanabusa and denied that the trade group had offered to run a campaign. A Hanabusa spokesman blamed a misinformed staffer.

From the Post:

A senior aide to Rep. Colleen Hanabusa (D-Hawaii) told his colleagues late last month that the nation’s top drug lobby had agreed to run a campaign supporting the congresswoman’s challenge to Democratic Sen. Brian Schatz and wanted to coordinate it with her strategists.

Such an effort, described in an e-mail obtained by The Washington Post, could run afoul of campaign finance laws, which prohibit candidates and their staff from substantial discussions with interest groups about their independent political activities.

Officials with the Pharmaceutical Research and Manufacturers of America (PhRMA) and Hanabusa’s campaign denied that the group had offered to run such an effort but acknowledged talks about a possible fundraiser for Hanabusa and about the state of the race in general.

Campaign officials blamed the e-mail on a misinformed staffer.

“He made inaccurate assumptions about the type of help PhRMA could provide the campaign,” campaign spokesman Peter Boylan said.

Matt Bennett, a spokesman for PhRMA, said officials there did not offer to do a campaign on Hanabusa’s behalf. But he said the group had “preliminary” discussions about hosting an industry fundraiser for Hanabusa through its political action committee.

He also said that a PhRMA lobbyist had spoken with Jennifer Sabas, a top Hanabusa campaign adviser, but that they had only talked about the state of the Democratic primary campaign in Hawaii.

“They discussed the race and what’s happening on the ground,” Bennett said.

Boylan echoed that, saying Sabas did not provide PhRMA with any information “that would constitute coordination in violation of the law.”

4 Responses to “Overture”

  1. Kolea:

    Big Pharma wants to help Hanabusa defeat Schatz? It appears the former Senate President is employing the same Special Interest approach to campaign contributions she developed so well as a state senator.

    Coordinating with an "independent campaign"? Of course, not. The staffer obviously misspoke. Had he NOT misspoken, he would have been more careful to employ ambiguous, plausibly deniability. Like that on display by Hanabusa's paid shill, Peter Boylan.

    This campaign has already gotten too gross. Her staffer has admitted a crime, conspiring to violate campaign spending laws. Let's stop the election and start the trial. Maybe Big Pharma, Monsanto and the Oil Industry will be willing to sponsor the jury?

  2. ohiaforest3400:

    Chee-hoo, Kolea, you are on a rhetorical roll! I can't wait to read what you write when you actually have an opinion about something, LOL!

  3. Goober:

    All it is is opinion.
    Assumption and approximation.
    Copy and paste or plagiasm.
    stand tough for understanding.

  4. Especially Incognito:

    V for Vandetta.
    Listen to William Tells Overture
    as Hawaii is destroyed by missionaries.

Leave a Reply

By participating in online discussions you acknowledge that you have agreed to the Star-Advertiser's TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. Because only subscribers are allowed to comment, we have your personal information and are able to contact you. If your comments are inappropriate, you may be banned from posting. To report comments that you believe do not follow our guidelines, email commentfeedback@staradvertiser.com.